Ipsen SA is a global biopharmaceutical company focused on innovation in oncology, rare diseases, and neuroscience, with a commitment to improving the quality of life for patients worldwide.
Ipsen Share Sustainability Performance
Climate
44%
Renewable Energy
Ipsen obtains 48% of its energy from renewable energies. Target value: 100%
Greenhouse Gas Emissions
Ipsen emits 56% of its CO2 Budget of 28,219 tons of CO2 equivalent. Target value: Less than 100% of CO2 Budget
Supply Chain
If you also look at the supply chain, Ipsen emits 3,8x its CO2 budget of 28,219 tons of CO2 equivalent. Target value: Less than 100% of CO2 Budget
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.